Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth.

Autor: Dudgeon, C1, Peng, R1, Wang, P1, Sebastiani, A1, Yu, J2, Zhang, L1
Zdroj: Oncogene. 11/15/2012, Vol. 31 Issue 46, p4848-4858. 11p. 7 Graphs.
Databáze: Academic Search Ultimate